Positive Health Online

Abstract

STRAUMSHEIM and colleagues, Arena Medisinske Senter, Sognsveien, Oslo, Norway evaluated the efficacy of homoeopathy in the prevention of migraine attacks and accompanying symptoms.

Background

Methodology

The authors conducted a randomized, double-blind, placebo-controlled clinical trial, consisting of a one-month registration period without treatment, followed by four months individualized homoeopathic treatment or identical placebo. Patients were stratified for common or classical migraine. Of the 73 patients who were randomized, 68 completed the trial.

Results

Baseline values were similar in the two groups, as were the migraine diaries. Both the homoeopathy and placebo groups had reduced attack frequencies, pain intensity and drug consumption. There was a statistically non-significant difference in favour of homoeopathy. The neurologists trial evaluation indicated a statistically significant reduction in attack frequency in the homoeopathy group and non-statistically significant trends in favour of homoeopathy for pain intensity and overall evaluation.

Conclusion

Further research incorporating improved trial design, regarding the potential role of homoeopathy in relief of migraine is justified.

References

Straumsheim P et al. Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients. The British Homoeopathic Journal 89(1): 4-7. Jan 2000.